Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

Tue, 12th Dec 2023 08:53

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

The FTSE 100 index opened up 33.30 points, 0.4%, at 7,578.19. The FTSE 250 was up 55.14 points, 0.3%, at 18,805.53, and the AIM All-Share was up 1.20 points, 0.2%, at 726.93.

The Cboe UK 100 was up 0.4% at 756.55, the Cboe UK 250 was up 0.4% at 16,327.61, and the Cboe Small Companies was up 0.3% at 14,045.17.

In the US on Monday, Wall Street ended higher, with both the Dow Jones Industrial Average and the S&P 500 up 0.4% and the Nasdaq Composite up 0.2%.

Stocks are edged higher ahead of a key week for investors and central bank policymakers. On Wednesday, markets will be eyeing an interest rate decision from the US Federal Reserve, while the European Central Bank and the Bank of England will make their own decisions on Thursday.

The Bank of England, European Central Bank and US Federal Reserve are all expected to leave interest rates unchanged this week.

Ahead of those, US consumer prices figures will be released on Tuesday afternoon by the Bureau of Labor Statistics.

According to FXStreet market consensus, the consumer price index is expected to rise by 3.1% annually in November, decelerating from 3.2% in October.

If CPI does decelerate, the rate of inflation will move closer to the Fed's 2% target.

"These numbers certainly look much better than what they did back in 2022, when we saw the US core inflation reach 6.6%," Swissquote Bank's Ipek Ozkardeskaya pointed out.

Early Tuesday, investors were digesting the latest unemployment data from the UK.

Figures from the Office for National Statistics showed that UK unemployment was steady at 4.2% in the three months to October. The unemployment rate came in line with FXStreet-cited market consensus.

In the three months to September, annual growth in average total pay, excluding bonuses, was 7.3%. This was slightly lower than market consensus of 7.4%. Growth in the previous three-month period was 7.8%.

The pound was quoted at USD1.2569 early on Tuesday in London, up compared to USD1.2545 at the equities close on Monday. The euro stood at USD1.0782, higher against USD1.0746. Against the yen, the dollar was trading at JPY145.53, lower compared to JPY146.52.

In the FTSE 100, Unilever lost 0.1%.

The UK competition regulator said it will investigate claims made by Unilever PLC about the environmental impact of its consumer products.

Unilever makes a wide variety of food & drink, cleaning, toiletry, and personal care products, including brands such as Cif, Dove, Comfort, and Lynx. The UK Competition & Markets Authority said it has contacted the London-based company about its claims that some of these products are environmentally friendly.

The CMA said its investigation of Unilever is part of a wider probe of corporate 'greenwashing' that it launched back in January.

Unilever didn't immediately respond to the CMA announcement early Tuesday.

AstraZeneca edged 1.0% higher.

It said it has entered into a definitive agreement to acquire Icosavax. Icosavax is a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential vaccines using an innovative, protein virus-like particle platform.

Astra said the proposed acquisition will build on AstraZeneca's expertise in respiratory syncytial virus, strengthening AstraZeneca's Vaccines & Immune Therapies late-stage pipeline with Icosavax's lead investigational vaccine candidate, IVX-A12.

In the FTSE 250 index, Chemring was down 0.9%, as its results failed to capture investor attention.

Chemring, a provider of technology products and services to aerospace, defence and security markets, provided its results for the year ended October 31.

It reported that revenue rose to GBP472.6 million from GBP401.0 million a year earlier. Underlying pretax profit jumped to GBP71.7 million from GBP57.9 million.

On the back of the results, Chemring upped its dividend per share by 21% to 6.9p from 5.7p.

Chief Executive Michael Ord said: "2023 was another year of strong group performance; and in an environment of increasing global uncertainty demand continues to grow for our mission-critical products and services. With record order intake and an order book at the highest level in over a decade the group is well placed for continued delivery of sustainable performance and growth."

On AIM, SmartSpace Software shares surged 91% to 63.90p.

The surge in share prices follows Skedda proposing to buy the Bury St Edmunds, England-based designer and builder of smart software solutions.

It has offered the company 82p per share, more than double the closing price of 33.5p on Monday. The offer values SmartSpace at GBP25.0 million.

Skedda commented: "Skedda is excited by a potential of a combination with SmartSpace. Skedda believes that it can provide SmartSpace with the considerable financial support and technical expertise that Skedda believes will be necessary for SmartSpace to maintain its technological advantage in a rapidly developing and increasingly competitive sector."

In Asia on Tuesday, the Nikkei 225 index in Tokyo closed up 0.2%. In China, the Shanghai Composite closed up 0.4%, while the Hang Seng index in Hong Kong was up 1.1% in late dealings. The S&P/ASX 200 in Sydney closed up 0.5%.

In European equities on Tuesday, the CAC 40 in Paris was up 0.3%, while the DAX 40 in Frankfurt was up 0.2%.

Brent oil was quoted at USD76.27 a barrel early in London on Tuesday, up from USD75.41 late Monday. Gold was quoted at USD1,986.42 an ounce, higher against USD1,981.92.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.